Cognition Therapeutics (CGTX) Stock Chart & Stock Price History $0.33 -0.01 (-3.02%) As of 10:28 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cognition Therapeutics Stock Price Performance The Cognition Therapeutics (CGTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 85.55%, with a year-to-date return of -53.23%. In the past month, the stock has decreased 9.79%, reflecting recent market activity. As of the latest close, Cognition Therapeutics traded at $0.34 with a market cap of $20.97 million and volume of 438,344 shares. Receive CGTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cognition Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.86%1 Month Performance-9.79%3 Month Performance-43.76%Year-To-Date Performance-53.23%1 Year Performance-85.55% CGTX Stock Chart for Wednesday, May, 21, 2025 CGTX Chart by TradingView Cognition Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/20/2025$0.33$0.34+2.48%$0.34$0.33438,344 shs$20.97 million05/19/2025$0.33$0.33+1.48%$0.34$0.32390,143 shs$20.46 million05/16/2025$0.32$0.33+3.21%$0.33$0.31384,963 shs$20.16 million05/15/2025$0.33$0.32-5.52%$0.33$0.31609,222 shs$19.53 million05/14/2025$0.32$0.33+3.83%$0.33$0.31811,877 shs$20.67 million05/13/2025$0.33$0.32-1.74%$0.33$0.30633,749 shs$19.91 million05/12/2025$0.30$0.33+8.97%$0.34$0.312.48 million shs$20.26 million05/09/2025$0.33$0.30-8.26%$0.32$0.282.53 million shs$18.59 million05/08/2025$0.35$0.33-7.81%$0.36$0.326.29 million shs$20.27 million05/07/2025$0.42$0.35-15.04%$0.40$0.35904,526 shs$21.98 million Get the Latest News and Ratings for CGTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cognition Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/06/2025$0.43$0.42-3.98%$0.44$0.41198,556 shs$25.88 million05/05/2025$0.45$0.43-2.47%$0.47$0.42484,188 shs$26.95 million05/02/2025$0.45$0.45-0.31%$0.47$0.43315,864 shs$27.63 million05/01/2025$0.43$0.45+4.76%$0.45$0.41340,528 shs$27.71 million04/30/2025$0.42$0.43+2.33%$0.43$0.40240,231 shs$26.46 million04/29/2025$0.42$0.42+0.17%$0.42$0.41181,853 shs$25.86 million04/28/2025$0.44$0.42-4.87%$0.44$0.40447,013 shs$25.81 million04/25/2025$0.44$0.44-0.82%$0.44$0.42417,748 shs$27.13 million04/24/2025$0.38$0.44+15.25%$0.45$0.391.35 million shs$27.36 million04/23/2025$0.38$0.38+1.56%$0.39$0.37193,447 shs$23.74 million04/22/2025$0.36$0.38+3.71%$0.38$0.36106,117 shs$23.37 million04/21/2025$0.37$0.36-2.36%$0.38$0.35254,384 shs$22.53 million Related Companies OncoCyte Stock Chart Adagene Stock Chart CervoMed Stock Chart TScan Therapeutics Stock Chart I-Mab Stock Chart Maxpro Capital Acquisition Stock Chart Inozyme Pharma Stock Chart Caribou Biosciences Stock Chart Adaptimmune Therapeutics Stock Chart Genenta Science Stock Chart Receive CGTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cognition Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CGTX) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cognition Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cognition Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CGTX Stock Free CGTX Stock Alerts